In the agonist opioid is heroin and in the antagonist opioid is naltrexone. Buprenorphine or Buprenex is another example of a mixed agonist-antagonist.
Agonist and Antagonist therapies are effective evidence-based options in the medical treatment of drug addiction. A simple way to think about these concepts is that agonist therapy creates an action while antagonist therapy opposes an action. Antagonist therapy has several benefits. Patients receiving antagonist drugs, such as Naltrexone, which is used in the treatment of opioid addiction, do not develop a tolerance to the medication. Additionally, antagonist drugs are not addictive in and of themselves. A drug that is an agonist attaches itself to receptors in the brain, and then produces a chemical reaction. For example, heroin is an opioid agonist. It binds to opioid receptors that control pleasure and pain, the result being a feeling of euphoria and well being. Other examples of opioid agonists, sometimes referred to as “full agonists,” are oxycodone, morphine and opium. Antagonist therapy has several benefits. Patients receiving antagonist drugs, such as Naltrexone, which is used in the treatment of opioid addiction, do not develop a tolerance to the medication. Additionally, antagonist drugs are not addictive in and of themselves. Antagonist Pharmacotherapy. Naltrexone is an opioid antagonist that blocks the effects of heroin and most other opioids. It does not have addictive properties or produce physical dependence, and tolerance does not develop. It has a long half-life, and its therapeutic effects can last up to 3 days. Naltrexone is not a stigmatized treatment. The antagonist blocks the receptor and prevemts activation by neurotransmitters or other drugs. So in the case of opiates, lets look at the opiate agonist, morphine. When morphine enters the brain, it binds to opiate receptors and activates them. This binding is what produces the effects of Morphine. The group includes drugs which act as an agonist or partial agonist at one receptor and an antagonist at another (pentazocine, butorphanol, nalbuphine, dezocine) and drugs acting as a partial agonist at a single receptor (buprenorphine). These drugs can be classified as nalorphine-like or morphine-like. Author information: (1)Royal Marsden Hospital, London, England. The agonist-antagonist opioid analgesics are a heterogeneous group of drugs with moderate to strong analgesic activity comparable to that of the pure agonist opioids such as codeine and morphine but with a limited effective dose range. Answer: Agonist-antagonist medicines represent a class of opiod medications that bind to both a receptor that produces pain relief, which is the agonist portion, and bind to another receptor that does not produce a physiological effect, which is the antagonist portion. Buprenorphine or Buprenex is another example of a mixed agonist-antagonist medicine that is growing in use due to its ability to produce good pain relief, its potential for reduced risk of respiratory depression, and its ability for use as a maintenance drug for opioid-dependent patients. Examples of opiate agonists include methadone and LAAM. These synthetic opiates help prevent cravings and withdrawal but do not produce a high or feelings of euphoria. An opiate antagonist is a drug that replaces opiate agonists at the receptor sites. This blocks the patient from experiencing the opiate effects of the agonist drug. Opiate antagonists include naloxone and naltrexone. Methadone is used therapeutically to treat addiction to opiates including heroin, morphine, OxyContin and other drugs. In the treatment of chronic opiate addiction, an opiate agonist can be used as maintenance therapy An antagonist is an agent that binds to a receptor but does not elicit the response that the neurotransmitter or an agonist would cause. The antagonist blocks the receptor and prevemts activation by neurotransmitters or other drugs. So in the case of opiates, lets look at the opiate agonist, morphine. When morphine enters the brain, it binds to opiate receptors and activates them. This binding is what produces the effects of Morphine. An opioid antagonist, or opioid receptor antagonist, is a receptor antagonist that acts on opioid receptors. Naloxone and naltrexone are commonly used opioid antagonist drugs which are competitive antagonists that bind to the opioid receptors with higher affinity than agonists but do not activate the receptors. This effectively blocks the receptor, preventing the body from responding to opioids and endorphins. Naloxone on the other hand has no partial agonist effects, and is in fact a partial inverse agonist at mu opioid receptors, and so is the preferred antidote drug for treating opioid overdose.
http://www.inspiremalibu.com/agonist-antagonist-therapy-treatment/ http://www.inspiremalibu.com/agonist-antagonist-therapy-treatment/ http://www.suboxoneassistedtreatment.org/29.html http://www.ncbi.nlm.nih.gov/pubmed/1711441 http://abcnews.go.com/Health/TreatingPain/story?id=4280358 https://www.opiates.com/opiate-agonist/ http://www.suboxoneassistedtreatment.org/29.html https://en.wikipedia.org/wiki/Opioid_antagonist
which opioids is an agonist and antagonist